Meropenem and Atherosclerosis - a phase IV clinical study of FDA data
Summary:
Atherosclerosis is reported as a side effect among people who take Meropenem (meropenem), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Clopidogrel, and have Sedation.
The phase IV clinical study analyzes which people have Atherosclerosis when taking Meropenem. It is created by eHealthMe based on reports of 33,250 people who have side effects when taking Meropenem from the FDA, and is updated regularly.
What is Meropenem?
Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.
What is Atherosclerosis?
Atherosclerosis (disorder of the arteries) is found to be associated with 1,201 drugs and 1,533 conditions by eHealthMe. Check the latest studies of Atherosclerosis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
33,250 people reported to have side effects when taking Meropenem.
Among them, 34 people (0.1%) have Atherosclerosis.

Among these 34 people:
How long have people been on Meropenem when they have Atherosclerosis? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Atherosclerosis when taking Meropenem? *
- female: 56.25 %
- male: 43.75 %
What is the age of people who have Atherosclerosis when taking Meropenem? *
- 0-1: 0.0 %
- 2-9: 3.23 %
- 10-19: 3.23 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 3.23 %
- 50-59: 51.61 %
- 60+: 38.71 %
What are other drugs people take besides Meropenem? *
- Clopidogrel: 17 people, 50.00%
- Simulect: 16 people, 47.06%
- Midazolam: 15 people, 44.12%
- Ciclosporin: 14 people, 41.18%
- Piperacillin And Tazobactam: 12 people, 35.29%
- Acetylsalicylic Acid: 11 people, 32.35%
- Vancomycin: 9 people, 26.47%
- Envarsus Xr: 6 people, 17.65%
- Lasix: 5 people, 14.71%
- Clonazepam: 5 people, 14.71%
What are other side effects people have besides Atherosclerosis? *
- Dyspnea (difficult or laboured breathing): 19 people, 55.88%
- Anaemia (lack of blood): 17 people, 50.00%
- Pneumonia: 17 people, 50.00%
- Acid Base Balance Abnormal: 16 people, 47.06%
- Loss Of Consciousness: 16 people, 47.06%
- Immunosuppressant Drug Level Increased: 16 people, 47.06%
- Hypotonia (low muscle tone): 16 people, 47.06%
- Haematoma (collection of blood outside the blood vessels): 16 people, 47.06%
- Extremity Necrosis (death of body tissue of arms and legs): 16 people, 47.06%
- Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 16 people, 47.06%
What are the existing conditions these people have? *
- Sedation: 16 people, 47.06%
- C-Reactive Protein Increased: 13 people, 38.24%
- Immune Tolerance Induction: 10 people, 29.41%
- Cardiac Disorder: 9 people, 26.47%
- Urinary Tract Infection: 8 people, 23.53%
- Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 7 people, 20.59%
- Cytomegalovirus Infection: 3 people, 8.82%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 5.88%
- Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 5.88%
- Gastric Ulcer (stomach ulcer): 2 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Meropenem and have Atherosclerosis?
- Check whether Atherosclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Meropenem:
- Meropenem (33,295 reports)
Atherosclerosis treatments and more:
- Atherosclerosis (21,888 reports)
How severe was Atherosclerosis and when was it recovered:
Expand to all the drugs that have ingredients of meropenem:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Atherosclerosis:
- Atherosclerosis (1,201 drugs)
Browse all the conditions that are associated with Atherosclerosis:
- Atherosclerosis (1,533 conditions)
Related publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ezetimibe cause Nervous System Disorder? - 5 seconds ago
- Could Repaglinide cause Abdominal Pain Upper? - 9 seconds ago
- Drug Hypersensitivity and High Blood Pressure - 10 seconds ago
- Could Boron cause Nausea Aggravated? - 12 seconds ago
- Could Melphalan cause Osteopenia? - 19 seconds ago
- Could Melphalan Hydrochloride cause Rashes? - 21 seconds ago
- Could Baby Aspirin cause Pharyngeal Oedema? - 21 seconds ago
- Could Boniva cause Wax Blockage? - 32 seconds ago
- Could Remodulin cause Premature Delivery? - 33 seconds ago
- Could Remodulin cause Chronic Obstructive Pulmonary Disease? - 34 seconds ago